Overview

A Study of DII235 in Adults With Elevated Lipoprotein(a)

Status:
NOT_YET_RECRUITING
Trial end date:
2028-09-08
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).
Phase:
PHASE2
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Sodium Chloride